Lipella Pharmaceuticals Inc. (Nasdaq: LIPO) (“Lipella” or the “Company”), a clinical-stage biotechnology company focused on ...

Lipella Pharmaceuticals Inc. (Nasdaq: LIPO) ("Lipella" or the "Company"), a clinical-stage biotechnology company focused on developing innovative therapies ...

PITTSBURGH - Lipella Pharmaceuticals Inc. (NASDAQ:LIPO), a biotech firm specializing in novel therapies for medical conditions lacking adequate treatments, has received FDA approval for an Expanded ...

The U.S. Food and Drug Administration (FDA) has approved ranibizumab injection (Susvimo, 100 mg/mL; Genentech) for the ...

Lisinopril can cause certain side effects, some of which are more common than others ... Note: After the FDA approves a drug, it tracks and reviews side effects of the medication.

A new opioid-free pain medication was approved by the FDA on Thursday, marking a non-addictive alternative for patients.

The US Food and Drug Administration signed off on the first new type of pain reliever to be approved in more than two decades ...

The outbreak marks Uganda's eighth from an Ebola virus. The first confirmed case in the outbreak was a nurse at a hospital in the nation's capital, Kampala, who contracted Ebola on Jan. 20 or Jan. 21 ...

Is this biotech stock a no-brainer buy now after its huge FDA ... approval filing after the cohort reaches 48 weeks of treatment. As they say on the infomercials, "But wait! There's more!" ...

The FDA has approved the first and only subcutaneous apomorphine infusion device, apomorphine hydrochloride injection (Onapgo ...

USE ONAPGO is a prescription medicine used to treat motor fluctuations (OFF episodes) in adults with advanced Parkinson’s disease (PD). It is not known if ONAPGO is safe and effective in children.

Independence Blue Cross’s recently announced policy bars coverage of FDA approved treatments until ... these few drugs based on the fact there is no research proving they are clinically ...